Merck KGaA plans to spend 100 million euros, or about $110 million, to build a new facility in Carlsbad, California, that will focus on viral vector and gene therapy production.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,